Serum Institute of India

Serum Institute of India Private Limited
Founder Cyrus S. Poonawalla
Headquarters Pune, India
Key people
Cyrus S. Poonawalla (Chairman & MD)
Revenue Increase US$595 million (2015)
Increase US$295 million (2015)
Website www.seruminstitute.com/ Edit this on Wikidata

Serum Institute of India Private Limited[1][2] is a manufacturer of immunobiological drugs including vaccines in India. The company is managed by the Poonawalla group which fully owned by Cyrus Poonawalla. The company was founded by Poonawalla in 1966.[3] It is the world's largest vaccine producer by number of doses produced.[4] The company is developing an intra-nasal swine flu vaccine.[5] Co-developed with US-based Mass Biologics of the University of Massachusetts Medical School, it invented a fast-acting anti-rabies agent, Rabies Human Monoclonal Antibody (RMAb).[6]

References

  1. "Serum Institute of India Pvt. Ltd.: Private Company Information". bloomberg.com. Retrieved 2018-09-30.
  2. "SERUM INSTITUTE OF INDIA PRIVATE LIMITED - Company, directors and contact details". zaubacorp.com. Retrieved 2018-09-30.
  3. "About Us". Serum Institute of India. Retrieved 8 December 2016.
  4. "Cyrus Poonawalla on Forbes Lists". Forbes. Retrieved 24 March 2015.
  5. "'India developing indigenous swine flu vaccine'". The Times of India. Retrieved 1 February 2015.
  6. "Fast-acting anti-rabies drug set for India launch - Times of India". The Times of India. Retrieved 2016-06-12.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.